ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Go back to ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 75.35 -1.97 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.32 | 52 Week High | $70.92 | |||
| Open | $77.33 | 52 Week Low | $26.80 | |||
| Day High | $77.81 | P/E | N/A | |||
| Day Low | $74.81 | EPS | $-0.96 | |||
| Volume | 379,162 | |||||
